Most cited papers from VisMederi Research

VisMederi Research

What are the most cited papers from VisMederi Research?

The most cited paper from VisMederi Research is "SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma" (Emanuele Andreano, Giulia Piccini, Danilo Licastro et al., 2021), with 378 citations. Next come "SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma" (281) and "Extremely potent human monoclonal antibodies from COVID-19 convalescent patients" (240).

Published TypeFieldAccessCitations

Showing 50 of 60 papers. Every paper with more than 29 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma Emanuele Andreano, Giulia Piccini, Danilo Licastro et al. · Proceedings of the National Academy of Sciences Open access	20 Aug 2021	378
2	SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma Emanuele Andreano, Giulia Piccini, Danilo Licastro et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	28 Dec 2020	281
3	Extremely potent human monoclonal antibodies from COVID-19 convalescent patients Emanuele Andreano et al. · Cell Open access	23 Feb 2021	240
4	Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 Syed Sohail Ahmed, Wayne Volkmuth, José S. Duca et al. · Science Translational Medicine Open access	Jul 2015	237
5	Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples Alessandro Manenti, Marta Maggetti, Elisa Casa et al. · Journal of Medical Virology Open access	8 May 2020	214
6	Inhibitory Receptors and Pathways of Lymphocytes: The Role of PD-1 in Treg Development and Their Involvement in Autoimmunity Onset and Cancer Progression Elena Gianchecchi, Alessandra Fierabracci · Frontiers in Immunology Open access	17 Oct 2018	214
7	Hybrid immunity improves B cells and antibodies against SARS-CoV-2 variants Emanuele Andreano, Ida Paciello, Giulia Piccini et al. · Nature Open access	20 Oct 2021	181
8	Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy Giovanni Apolone, Emanuele Montomoli, Alessandro Manenti et al. · Tumori Journal Open access	11 Nov 2020	178
9	Influenza Viruses and Vaccines: The Role of Vaccine Effectiveness Studies for Evaluation of the Benefits of Influenza Vaccines Claudia Maria Trombetta, Otfried Kistner, Emanuele Montomoli et al. · Vaccines Open access	May 2022	149
10	Influenza immunology evaluation and correlates of protection: a focus on vaccines Claudia Maria Trombetta, Emanuele Montomoli · Expert Review of Vaccines Open access	8 Mar 2016	126
11	Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future Claudia Maria Trombetta, Daniele Perini, Stuart T. Mather et al. · Vaccines Open access	13 Oct 2014	118
12	Yellow Fever: Origin, Epidemiology, Preventive Strategies and Future Prospects Elena Gianchecchi, Virginia Cianchi, Alessandro Torelli et al. · Vaccines Open access	27 Feb 2022	103
13	Epidemiology and prevention of Human Papillomavirus. Ilaria Manini, Emanuele Montomoli · PubMed	24 Oct 2019	97
14	Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples Livia Mazzini, Donata Martinuzzi, Inesa Hyseni et al. · Journal of Immunological Methods Open access	27 Nov 2020	86
15	Serological follow-up of SARS-CoV-2 asymptomatic subjects Gregorio Paolo Milani et al. · Scientific Reports Open access	18 Nov 2020	86
16	Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays Inesa Hyseni, Eleonora Molesti, Linda Benincasa et al. · Viruses Open access	10 Sep 2020	82
17	Influenza D Virus: Serological Evidence in the Italian Population from 2005 to 2017 Claudia Maria Trombetta, Serena Marchi, Ilaria Manini et al. · Viruses Open access	27 Dec 2019	82
18	Influenza vaccines: Evaluation of the safety profile Claudia Maria Trombetta, Elena Gianchecchi, Emanuele Montomoli · Human Vaccines & Immunotherapeutics Open access	3 Jan 2018	82
19	Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity Elena Gianchecchi, Alessandra Fierabracci · International Journal of Molecular Sciences Open access	11 Jan 2019	75
20	Egg-Independent Influenza Vaccines and Vaccine Candidates Ilaria Manini, Claudia Maria Trombetta, Giacomo Lazzeri et al. · Vaccines Open access	18 Jul 2017	75
21	Evaluation of the automated LIAISON® SARS-CoV-2 TrimericS IgG assay for the detection of circulating antibodies Fabrizio Bonelli, Frank A. Blocki, Tina Bunnell et al. · Clinical Chemistry and Laboratory Medicine (CCLM) Open access	13 Mar 2021	74
22	Natural Killer Cells: Potential Biomarkers and Therapeutic Target in Autoimmune Diseases? Elena Gianchecchi, Domenico Vittorio Delfino, Alessandra Fierabracci · Frontiers in Immunology Open access	19 Feb 2021	73
23	Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses Claudia Maria Trombetta, Edmond J. Remarque, Daniëlla Mortier et al. · Influenza and Other Respiratory Viruses Open access	19 Jul 2018	73
24	Insights on the Effects of Resveratrol and Some of Its Derivatives in Cancer and Autoimmunity: A Molecule with a Dual Activity Elena Gianchecchi, Alessandra Fierabracci · Antioxidants Open access	22 Jan 2020	72
25	Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap? Giovanna Milano, Giovanni Guarducci, Nicola Nante et al. · Vaccines Open access	4 Jun 2023	69
26	Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments Elena Gianchecchi, Andrea Arena, Alessandra Fierabracci · International Journal of Molecular Sciences Open access	28 May 2021	60
27	Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production Emanuele Montomoli, Baharak Khadang, Simona Piccirella et al. · Expert Review of Vaccines	May 2012	60
28	Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils Kristin Greve-Isdahl Mohn, Karl Albert Brokstad, Rishi D. Pathirana et al. · The Journal of Infectious Diseases Open access	30 May 2016	59
29	Flucelvax (Optaflu) for seasonal influenza Ilaria Manini, Alexander Domnich, Daniela Amicizia et al. · Expert Review of Vaccines Open access	12 May 2015	54
30	Early Rise of Blood T Follicular Helper Cell Subsets and Baseline Immunity as Predictors of Persisting Late Functional Antibody Responses to Vaccination in Humans Fabiana Spensieri, Emilio Siena, Erica Borgogni et al. · PLoS ONE Open access	23 Jun 2016	50
31	How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions Elena Gianchecchi, Alessandro Manenti, Otfried Kistner et al. · Influenza and Other Respiratory Viruses Open access	21 Jun 2019	48
32	Gene/environment interactions in the pathogenesis of autoimmunity: New insights on the role of Toll-like receptors Elena Gianchecchi, Alessandra Fierabracci · Autoimmunity Reviews	13 Jul 2015	48
33	Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens Alessandra Gallinaro, Martina Borghi, Roberta Bona et al. · Frontiers in Immunology Open access	5 Feb 2018	47
34	Challenges in the development of egg-independent vaccines for influenza Claudia Maria Trombetta, Serena Marchi, Ilaria Manini et al. · Expert Review of Vaccines	2 Jul 2019	46
35	Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study over 15 years Serena Marchi, Claudia Maria Trombetta, Roberto Gasparini et al. · PubMed Open access	15 Nov 2016	46
36	Type 1 Diabetes and Its Multi-Factorial Pathogenesis: The Putative Role of NK Cells Valeria La Marca, Elena Gianchecchi, Alessandra Fierabracci · International Journal of Molecular Sciences Open access	10 Mar 2018	44
37	GRT-R910: a self-amplifying mRNA SARS-CoV-2 vaccine boosts immunity for ≥6 months in previously-vaccinated older adults Christine D. Palmer et al. · Nature Communications Open access	6 Jun 2023	43
38	Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects Alessandro Manenti, Elena Gianchecchi, Francesca Dapporto et al. · Journal of Immunological Methods Open access	26 Nov 2021	43
39	Characterization of antibody response in asymptomatic and symptomatic SARS-CoV-2 infection Serena Marchi, Simonetta Viviani, Edmond J. Remarque et al. · PLoS ONE Open access	2 Jul 2021	43
40	Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 Daniela Fanigliulo, Serena Marchi, Emanuele Montomoli et al. · Parasite Open access	2020	43
41	Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study Gianni Carraro, Agostino Naso, Emanuele Montomoli et al. · Vaccine	14 Dec 2011	43
42	Emerging Influenza Strains in the Last Two Decades: A Threat of a New Pandemic? Claudia Maria Trombetta, Simona Piccirella, Daniele Perini et al. · Vaccines Open access	18 Mar 2015	43
43	Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement Federica Sicca, Donata Martinuzzi, Emanuele Montomoli et al. · Vaccine Open access	7 Feb 2020	42
44	Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody Jonathan L. Torres et al. · Proceedings of the National Academy of Sciences Open access	12 May 2022	41
45	Intranasal administration of a virus like particles‐based vaccine induces neutralizing antibodies against SARS‐CoV‐2 and variants of concern Dominik A. Rothen, Pascal S. Krenger, Aleksandra Nonic et al. · Allergy Open access	11 Apr 2022	40
46	The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity Elena Gianchecchi, Alessandro Torelli, Emanuele Montomoli · Human Vaccines & Immunotherapeutics Open access	8 Jan 2019	40
47	Emerging and Re-emerging Arboviral Diseases as a Global Health Problem Serena Marchi, Claudia Maria Trombetta, Emanuele Montomoli · InTech eBooks Book chapterOpen access	17 Oct 2018	38
48	A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine Signe C. Svindland, Gabriel Kristian Pedersen, Rishi D. Pathirana et al. · Influenza and Other Respiratory Viruses Open access	21 Nov 2012	38
49	Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination Alessandro Manenti, Sarah M. Tete, Kristin G. I. Mohn et al. · Vaccine Open access	24 Oct 2016	35
50	Detection of antibodies against influenza D virus in swine veterinarians in Italy in 2004 Claudia Maria Trombetta, Emanuele Montomoli, Ilaria Di Bartolo et al. · Journal of Medical Virology Open access	23 Nov 2021	34

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.